Julius Birnbaum, M.D.
Amit Golding, M.D., Ph.D.
Dimitrios Pappas, M.D.
Ami Shah, M.D.
Peter Wung, M.D.
Rebecca Manno, M.D.
Janet Maynard, M.D.
Ritu Valiyil, M.D.
I have a particular interest in elaborating the mechanisms driving the neurological expressions of rheumatic disease, having completed a Neurology Residency prior to additional training in Internal Medicine and Rheumatology I feel that collaborating with colleagues in both Rheumatology and Neuroimmunology can potentially yield swift, incisive, and catalytic approaches to understanding the role of inflammation in neurological manifestations of rheumatic disease. The field of MS has been revolutionized by stratification of subpopulations on the basis of whether disease presentation is marked predominantly by inflammation (i.e. relapsing/remitting MS), or whether there is an insidiously although relentless progession of neurological deficits without similar "flares". In comparison to MS, the study of neurological manifestations often depends on vague nosological descriptions. Utilization of paraclinical data that can easily be stratified (i.e. Gad enhancing lesions on MRI, cytokine analysis and proteomics on CSF) according to surrogate definitions of inflammation offers potential mechanistic insight. At Hopkins, there is an unparalleled opportunity to weave phenomenology and more precise molecular biomarkers of inflammation, so that our understanding of the neurological disorders of rheumatic disease can rise to similar sophistication that has been seen in MS and paraneoplastic disorders. | |
| |
Prior training: MD, PhD from Johns Hopkins Medical School. Residency in internal medicine at Johns Hopkins Bayview Medical Center.
| |
| |
Dr. Dimitrios Pappas completed his medical education at Aristotle University
| |
| |
Dr. Ami Shah graduated from the Johns Hopkins University School of Medicine
| |
| |
Dr. Peter Wung is a graduate of the Ohio State University School of | |





